303 related articles for article (PubMed ID: 9096440)
1. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
[TBL] [Abstract][Full Text] [Related]
2. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH
Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon.
Lin CY
Kidney Int; 1995 Jan; 47(1):225-30. PubMed ID: 7731150
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
5. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL
PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
Ozdamar SO; Gucer S; Tinaztepe K
Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
[TBL] [Abstract][Full Text] [Related]
7. Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs.
Ouzan D; Pénaranda G; Joly H; Khiri H; Pironti A; Halfon P
J Clin Virol; 2013 Dec; 58(4):713-7. PubMed ID: 24183313
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
Zheng XY; Wei RB; Tang L; Li P; Zheng XD
World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
[TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
[TBL] [Abstract][Full Text] [Related]
10. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
Carreño V; Marcellin P; Hadziyannis S; Salmerón J; Diago M; Kitis GE; Vafiadis I; Schalm SW; Zahm F; Manzarbeitia F; Jiménez FJ; Quiroga JA
Hepatology; 1999 Jul; 30(1):277-82. PubMed ID: 10385667
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir.
Reijnders JG; Rijckborst V; Sonneveld MJ; Scherbeijn SM; Boucher CA; Hansen BE; Janssen HL
J Hepatol; 2011 Mar; 54(3):449-54. PubMed ID: 21112655
[TBL] [Abstract][Full Text] [Related]
12. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
Stancek D; Hajnická V; Blaskovicová H; Sudová J; Laktis K; Janota S; Jezek P
Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456
[TBL] [Abstract][Full Text] [Related]
13. Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.
Zylberberg H; Jiang J; Pialoux G; Driss F; Carnot F; Dubois F; Brechot C; Berthelot P; Pol S
Gastroenterol Clin Biol; 1996; 20(11):968-71. PubMed ID: 9119186
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
[TBL] [Abstract][Full Text] [Related]
15. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
[TBL] [Abstract][Full Text] [Related]
16. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
[TBL] [Abstract][Full Text] [Related]
17. Is there a hepatitis B virus-associated glomerulonephritis? Identification of HBsAG, HBcAG and HBeAG in kidney with monoclonal antibodies.
Zhang JH; Li LS; Zhou H
Chin Med J (Engl); 1989 Jul; 102(7):496-504. PubMed ID: 2517065
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
Li D; Gao G; Jiang H; Tang Z; Yu Y; Zang G
Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):65-9. PubMed ID: 25386761
[TBL] [Abstract][Full Text] [Related]
19. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
[TBL] [Abstract][Full Text] [Related]
20. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]